Capital Analysts LLC’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-547
| Closed | -$3K | – | 1326 |
|
|
2024
Q2 | $3K | Hold |
547
| – | – | ﹤0.01% | 1080 |
|
|
2024
Q1 | $4K | Hold |
547
| – | – | ﹤0.01% | 994 |
|
|
2023
Q4 | $4K | Hold |
547
| – | – | ﹤0.01% | 974 |
|
|
2023
Q3 | $3K | Sell |
547
-58
| -10% | -$318 | ﹤0.01% | 1017 |
|
|
2023
Q2 | $5K | Hold |
605
| – | – | ﹤0.01% | 883 |
|
|
2023
Q1 | $4K | Hold |
605
| – | – | ﹤0.01% | 878 |
|
|
2022
Q4 | $4K | Hold |
605
| – | – | ﹤0.01% | 928 |
|
|
2022
Q3 | $5K | Hold |
605
| – | – | ﹤0.01% | 883 |
|
|
2022
Q2 | $8K | Hold |
605
| – | – | ﹤0.01% | 824 |
|
|
2022
Q1 | $9K | Hold |
605
| – | – | ﹤0.01% | 760 |
|
|
2021
Q4 | $14K | Hold |
605
| – | – | ﹤0.01% | 766 |
|
|
2021
Q3 | $8K | Hold |
605
| – | – | ﹤0.01% | 815 |
|
|
2021
Q2 | $6K | Hold |
605
| – | – | ﹤0.01% | 798 |
|
|
2021
Q1 | $8K | Buy |
+605
| New | +$8K | ﹤0.01% | 819 |
|